Full-Time

National Account Manager

Confirmed live in the last 24 hours

Insulet Corporation

Insulet Corporation

1,001-5,000 employees

Biotechnology
Healthcare

Mid, Senior

United Kingdom

Field-based role requiring travel within assigned territory and occasional travel to West London.

Category
Strategic Account Management
Sales & Account Management
Required Skills
Data Analysis
Requirements
  • Bachelor’s degree in a relevant discipline (eg biochemistry, pharmacology, health economics)
  • Considerable experience in pharmaceutical and/or medical device market access
  • Proven reimbursement success for new products and line extensions
  • Strong and evolving knowledge of the policy, access and NHS landscape
  • Strong therapy area and product knowledge, with commitment to continuous learning
  • An ability to take large amounts of complex information and establish what is important
  • An ability to work as part of a multi-disciplinary team, and to influence without authority, as well as to operate independently and with initiative
  • Excellent verbal and written communication skills and ability to communicate both externally and internally at multiple levels of the organisation
Responsibilities
  • Creating and delivering strong value narratives (qualitative and quantitative) that remove barriers and shape access space for the future
  • Leading innovative payer and stakeholder engagement, including partnering with NHS and other access facilitating bodies
  • Focusing on data, including data analysis and data-based tools as well as having curiosity to explore the possibilities of data-based access approaches
  • Understanding policy and policy drivers and their relevance to market access goals and strategies

Company Stage

IPO

Total Funding

$134.6M

Headquarters

Acton, Massachusetts

Founded

N/A

Growth & Insights
Headcount

6 month growth

9%

1 year growth

19%

2 year growth

38%
Simplify Jobs

Simplify's Take

What believers are saying

  • The full market release of the Omnipod 5 App for iPhone in the U.S. positions Insulet to capture a significant share of the mobile health market.
  • Significant investments from firms like Baillie Gifford & Co. reflect strong confidence in Insulet's growth potential and market leadership.
  • The new manufacturing facility in Malaysia is expected to create over 1,000 jobs, indicating robust operational expansion and economic impact.

What critics are saying

  • The competitive landscape in insulin delivery technology could challenge Insulet's market position if innovation slows.
  • The integration of new technologies like the G7 and Libre 2 Plus sensors requires seamless execution to avoid potential technical setbacks.

What makes Insulet Corporation unique

  • Insulet Corporation is a global leader in tubeless insulin pump technology, setting it apart from traditional insulin delivery methods.
  • The Omnipod 5's integration with the Freestyle Libre 2 Plus sensor offers a unique real-time glucose monitoring solution, enhancing user experience.
  • Insulet's strategic expansion with a new manufacturing facility in Malaysia demonstrates its commitment to scaling production and meeting global demand.

Help us improve and share your feedback! Did you find this helpful?